#Italy #Milan #Bracco Imaging #Avicenna.AI #AiMIFY

Bracco Imaging Launches AiMIFY® and Partners with Avicenna.AI

At the 2026 European Congress of Radiology (ECR), Bracco Imaging S.p.A., a prominent player in diagnostic imaging, revealed two significant advancements in its AI Digital Health strategy. The first is the commercial launch of AiMIFY®, an AI-driven contrast enhancement solution, developed in partnership with Subtle Medical, Inc. This innovative technology aims to revolutionize the interpretation of brain MR images by optimizing the clarity of post-contrast images. The second announcement is a strategic alliance with Avicenna.AI, a frontrunner in medical AI solutions focused on improving clinical decision-making processes through advanced imaging capabilities.

The Significance of AiMIFY®

AiMIFY® leverages cutting-edge artificial intelligence techniques to heighten the efficacy of gadolinium-based contrast agents (GBCA) during brain MRI scans. As a result, radiologists and neuroradiologists can now achieve more precise assessments when detecting brain lesions, all while following established imaging protocols and standards of care. Dr. Ajit Shankaranarayanan, Chief Product Officer at Subtle Medical, emphasized the solution's goal: “AiMIFY® aims to maximize diagnostic accuracy while ensuring adherence to current practice standards.”

This launch is a key milestone for Bracco Imaging, aimed at broadening the global access to AI-enhanced MRI technology.

Partnership with Avicenna.AI

Alongside the launch of AiMIFY®, Bracco also announced a collaborative partnership with Avicenna.AI, focusing on pioneering AI applications within contrast-enhanced computed tomography (CT). The partnership will predominantly center on innovations in computer-aided detection and diagnosis for brain CT angiography. Progress is currently being made on this technology through development and clinical validation across select locations in the United States and Europe. An FDA submission for these new AI tools is anticipated by the latter half of 2026.

Cyril Di Grandi, Co-founder and CEO of Avicenna.AI, remarked on the significance of this collaboration: “Our partnership with Bracco opens the door for groundbreaking advancements in AI-driven solutions that assist radiologists in making timely and informed decisions.” The integration of Avicenna.AI’s expertise in interpretive AI with Bracco's longstanding leadership in imaging enhances the potential for future developments in radiology.

Commitment to Innovation

Fabio Tedoldi, Head of Global RD at Bracco Imaging, stated, “For nearly a century, our mission has been to shape the diagnostic imaging landscape through meaningful innovation and strategic partnerships.” The collaboration with Avicenna.AI illustrates Bracco's ongoing commitment to utilize AI for image interpretation, thereby augmenting support for radiologists throughout the imaging workflow—from acquisition to analysis. This will empower professionals to manage the increasing complexity of medical imaging while maintaining diagnostic confidence and efficiency in patient pathways.

The launch of AiMIFY® not only strengthens Bracco's existing MRI product lines but also furthers its investment in digital solutions that enhance the radiological experience. Both AiMIFY® and the partnership with Avicenna.AI will feature prominently in dedicated sessions at ECR 2026, further cementing Bracco’s position at the forefront of AI in healthcare.

By embracing these innovations, Bracco Imaging is steering the future of diagnostic imaging toward a more efficient and effective model, ultimately benefiting patients and healthcare professionals alike. For more information about Bracco’s involvement in ECR 2026, visit their website and stay tuned for insights into how AiMIFY® and their new partnerships are shaping the future of medical imaging.

About Bracco Imaging

Bracco Imaging has dedicated itself to improving the quality of life through innovation in diagnostic imaging since its inception in 1927. With over 3,800 employees globally, Bracco provides a comprehensive range of contrast agents and medical devices to enhance imaging for X-ray, CT, MRI, and Molecular Imaging methods, serving professionals and patients in more than 100 countries. For more details, visit Bracco Imaging.